Table 1. Clinical data of patients.
| Clinical data | PDR (n=33) | MH (n=20) | P value |
|---|---|---|---|
| age, y±SD |
63.27±11.9 |
71.2±10.2 |
0.02 |
| sex |
16 men (48.5%)
17 women (51.5%) |
8 men (40.0%)
12 women (60.0%) |
0.32 |
| duration of diabetes, y±SD |
13.85±9.07 |
0 |
|
| incidence of insulin therapy, n (%) |
24 (72.7%) |
0 |
|
| HbA1c, %±SD |
7.93±0.98 |
0 |
|
| incidence of arterial hypertension, n (%) |
31 (93.9%) |
7 (31.8%) |
0.0001 |
| incidence of hyperlipidemia, n (%) |
19 (57.6%) |
6 (27.3%) |
0.0001 |
| BMI, kg/m2±SD |
30.84±4.66 |
24.0±6.3 |
0.0001 |
| incidence of NVI, n |
2 (6.1%) |
0 |
|
| activity of disease | active 25 (75.8%) inactive 8 (24.2%) | 0 |
Legend: PDR – proliferative diabetic retinopathy; MH – macular hole; BMI – body mass index; NVI – iris neovascularization